MD3499G2 - Method of differentiated treatment of endometrial cancer - Google Patents
Method of differentiated treatment of endometrial cancerInfo
- Publication number
- MD3499G2 MD3499G2 MDA20070281A MD20070281A MD3499G2 MD 3499 G2 MD3499 G2 MD 3499G2 MD A20070281 A MDA20070281 A MD A20070281A MD 20070281 A MD20070281 A MD 20070281A MD 3499 G2 MD3499 G2 MD 3499G2
- Authority
- MD
- Moldova
- Prior art keywords
- level
- tryptophanhydroxylase
- myometrium
- stage
- degree
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention refers to medicine, in particular to the gynecologic oncology.Summary of the method of differentiated treatment of endometrial cancer consists in that it is determined the stage of disease, the degree of difference, the level of myometrium invasion, it is determined the level of tryptophanhydroxylase-1. Where the level of tryptophanhydroxylase-1 is above 13,8 conventional units, and to the patients is established the stage of disease IA, IB, the degree of difference 1, 2 and 3, the level of myometrium invasion under 50% or the stage IC, the degree of difference 1 and 2 and the level of myometrium invasion above 50%, it is carried out the total hysterectomy with bilateral salpingo-oophorectomy. Where the level of tryptophanhydroxylase-1 varies from 3,6 up to 13,8 conventional units, after hysterectomy, there are additionally prescribed two courses of chemotherapy with Cysplatinum - 100 mg/m2, drop-by-drop during 4 hours, once to the course and concomitantly it is prescribed the hormonotherapy with Depo-provera - 500 mg, intramuscularly, once a week and the antiestrogentherapy with Tamoxifen - 20 mg/day, the course constituting 3 months with an interval of 3 weeks between courses.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20070281A MD3499G2 (en) | 2007-10-12 | 2007-10-12 | Method of differentiated treatment of endometrial cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20070281A MD3499G2 (en) | 2007-10-12 | 2007-10-12 | Method of differentiated treatment of endometrial cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
MD3499F1 MD3499F1 (en) | 2008-02-29 |
MD3499G2 true MD3499G2 (en) | 2008-09-30 |
Family
ID=39156456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20070281A MD3499G2 (en) | 2007-10-12 | 2007-10-12 | Method of differentiated treatment of endometrial cancer |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD3499G2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2547569C1 (en) * | 2014-02-03 | 2015-04-10 | Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации | Method of treating patients suffering locally advanced cervical cancer |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD186C2 (en) * | 1994-03-01 | 1995-09-30 | Etco Ludmila | Method of endometritis treatment after cesarean section |
MD2377G2 (en) * | 2003-09-18 | 2004-08-31 | Институтул Де Черчетэрь Штиинцифиче Ын Домениул Окротирий Сэнэтэуий Мамей Ши Копилулуй Ал Министерулуй Сэнэтэций | Method of treatment of puerperal endometritis |
MD3222G2 (en) * | 2006-03-22 | 2007-08-31 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method of endometrial cancer diagnosis |
-
2007
- 2007-10-12 MD MDA20070281A patent/MD3499G2/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MD186C2 (en) * | 1994-03-01 | 1995-09-30 | Etco Ludmila | Method of endometritis treatment after cesarean section |
MD2377G2 (en) * | 2003-09-18 | 2004-08-31 | Институтул Де Черчетэрь Штиинцифиче Ын Домениул Окротирий Сэнэтэуий Мамей Ши Копилулуй Ал Министерулуй Сэнэтэций | Method of treatment of puerperal endometritis |
MD3222G2 (en) * | 2006-03-22 | 2007-08-31 | Общественное Медико-Санитарное Учреждение Онкологический Институт | Method of endometrial cancer diagnosis |
Non-Patent Citations (1)
Title |
---|
Huntsman D.G., Clement P.B., Gilks C.B., Scully R.E. Small-cell carcinoma of the endometrium. A clinicopathological study of sixteen cases. Am. J. Surg. Pathol. Nr. 18, 1994, p. 364-375 * |
Also Published As
Publication number | Publication date |
---|---|
MD3499F1 (en) | 2008-02-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ703940A (en) | Pharmaceutical combinations comprising a b-raf inhibitor, an egfr inhibitor and optionally a pi3k-alpha inhibitor | |
WO2010031825A3 (en) | Methods and compositions for the treatment of cancer | |
EA201691454A1 (en) | COMPOSITIONS OF PRIDOPIDININE MODIFIED SHIPPING | |
MX367341B (en) | TETRAHYDRONAPHTHYRIDINE AND RELATED BICYCLIC COMPOUNDS FOR INHIBITION OF RORgamma ACTIVITY AND THE TREATMENT OF DISEASE. | |
MX2014010590A (en) | Combination therapy (vemrufenib and a mdm2 inhibitor) for the treatment proliferative disorders. | |
UA85702C2 (en) | 3-[4-heterocyclyl -1,2,3,-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases | |
TNSN08375A1 (en) | Quinazolines for pdk1 inhibition | |
SG10201407403UA (en) | Treatments For Gastrointestinal Disorders | |
MX2014002967A (en) | Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells. | |
WO2015095834A3 (en) | Cancer treatments using erk1/2 and bcl-2 family inhibitors | |
WO2012078633A3 (en) | Methods of inhibiting metastasis from cancer | |
JP2016525097A5 (en) | ||
MX362855B (en) | Quinazolinone derivatives as parp inhibitors. | |
MX349719B (en) | Pharmaceutical formulations containing rifaximin, processes for their obtainment and method of treating intestinal disease. | |
TW200603804A (en) | Treatment with irinotecan (cpt-11) and an EGFR-inhibitor | |
WO2009048958A3 (en) | Methods and compositions involving chitosan nanoparticles | |
MY161288A (en) | Combination anti - cancer therapy | |
TN2012000046A1 (en) | Pharmaceutical compositions for the treatment of cancer and other diseases or disorfers | |
IN2015DN00528A (en) | ||
MX2022011372A (en) | Zinc-î³-pga compositions and methods for treating cancer. | |
MA34815B1 (en) | COMPOSITIONS COMPRISING A PI3K INHIBITOR AND A MEK INHIBITOR AND THEIR USE FOR THE TREATMENT OF CANCER | |
NZ598171A (en) | Methods and compositions for treating thyroid-related medical conditions with reduced folates | |
TW200608959A (en) | Treatment with oxaliplatin and an egfr-inhibitor | |
WO2011066082A3 (en) | Markers associated with ribavirin-induced anemia | |
MD3499G2 (en) | Method of differentiated treatment of endometrial cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |